OncotypeDx Breast Cancer Assay: Outcome Results from Real Life Big Data Studies
600,000 בדיקות בעולם
17:30-18:30 Cocktail & Dinner Reception
18:30-19:00 Greetings & Opening Remarks
19:00-19:30 Practical applied genomics in early breast cancer: The development and validation of Oncotype Dx
Norman Wolmark, M.D.
Chairman and Principal Investigator of the National Surgical Adjuvant Breast and Bowel Project (NSABP), Professor and Chairman of Human Oncology, Drexel University School of Medicine Philadelphia, Pennsylvania.
19:30-20:00 TAILORx and the Power of Prospective Outcomes Data
Steve Shak, M.D.
Executive Vice President of Research and Development, Genomic Health Inc.
20:00-20:20 Real-life Analysis Evaluating Treatments and Outcomes in Clalit Breast Cancer Patients for whom Adjuvant Treatment Decisions Incorporated the 21-gene Recurrence Score Results (Median Follow-up >5 Years)
Salomon M. Stemmer, M.D.
Head, Research Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center. Affiliated to the Sackler Faculty of Medicine.
20:20-20:45 Questions & Discussion
20:45–21:15 Desserts & Good bye